News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
A near-term rebound contrasts with deeper medium-term losses before the oncology biotech reports.
Diversified and Resilient Business Model Delivers Steady Growth ISTANBUL, August 13, 2026--(BUSINESS WIRE)--Turkcell (NYSE:TKC) (BIST:TCELL): Please note that all financial data is consolidated and comprises that of Turkcell İletişim Hizmetleri A.S. (the "Company" or "Turkcell") and its subsidiaries and associates (together referred to as …
Faruqi & Faruqi, LLP is investigating potential claims against BioXcel Therapeutics, Inc. (NASDAQ: BTAI) and reminds investors of the September 5, 2023, deadline to seek the role of lead plaintiff in a federal securities class action. The lawsuit stems from allegations that BioXcel made …
Cellebrite DI Ltd. (CLBT) stock has crashed to $10.22 following a post-earnings decline, placing it deep in oversold territory according to its RSI readings across multiple timeframes. The company missed annual recurring revenue expectations due to delayed transactions and slower customer migration gains, leading …
Suzano S.A. (SUZB3) reported strong operational results and robust free cash flow in Q2 2026, alongside progress in Arbex integration. Despite global cost pressures, the company maintains its guidance for lower cash costs and deleveraging, anticipating efficiency gains in the second half of the …
FuelCell Energy's new power-generating carbon capture technology, which integrates into plant exhaust streams to reduce emissions and produce electricity, reinforces the company's investment thesis. While this innovation offers potential for an additional revenue stream and scalability, the immediate impact on its financial picture remains …
Cellebrite DI (NASDAQ:CLBT) shares recently fell to a new 52-week low of $10.55, despite previously closing at $15.25. While insider selling totaling $2.48 million occurred over the last three months, analysts maintain a "Moderate Buy" consensus with an average price target of $21.80. Institutional …
UPS jet_ United Parcel Service, By Carlos Yudica With a market cap of $88.3 billion, United Parcel Service, Inc. (UPS) is one of the world's largest logistics companies, serving customers across more than 200 countries and territories. With approximately 460,000 employees, UPS is guided …
Sharemaestro market context Price below Trend Line 52 weeks +7.8%Ashley B. Duffie, Senior Vice President and General Counsel of Celanese Corp (NYSE:CE), purchased 600 shares of the company's common stock on August 11, 2026, at $45.6 per share. This open market transaction increases Duffie's direct ownership to 31,925 shares, with an additional 691.4868 …
Cellectar Biosciences reported a wider-than-expected Q2 2026 loss of $0.57 per share, but its stock rose in premarket trading due to a stronger cash position and clinical progress for its lead drug, iopofosine I-131, in Waldenstrom’s macroglobulinemia (WM). The company secured up to $140 …
Suzano S.A. reported a significant drop in net income to R$1.8 billion in Q2 2026, down from R$5.0 billion a year earlier, primarily due to a weaker net financial result and higher costs. Despite this, the company maintained strong adjusted free cash flow of …
Celanese Corp director Edward G. Galante received two equity-based compensation awards: 1,930 shares of Common Stock as fully vested restricted stock units for his prior service as Chair of the Board, and 4.595 shares of phantom stock as dividend equivalents. These awards increased his …
Cellebrite DI Ltd. has appointed Shiven Ramji as its new CEO, succeeding Thomas E. Hogan, to sharpen its product strategy with a focus on AI and new growth opportunities. Ramji, previously president of products and technology, will lead the company's expansion beyond digital forensics …
Xcel Brands Inc (XELB) is scheduled to release its Q2 2026 earnings on August 14, 2026, with revenue and earnings per share estimates showing recent declines. Analysts project an average target price of $4.00, implying a 292.16% upside, while GuruFocus's GF Value suggests an …
Omnicell (OMCL) has raised its 2026 earnings outlook after a strong second quarter, though a significant portion of the profit improvement came from a one-time tariff refund. The company faces increased memory-chip costs expected to impact gross margins but plans to leverage cost control …
Suzano S.A. reported a significant increase in adjusted free cash flow to R$3.3 billion in Q2 2026, driven by higher prices and volumes, despite a year-on-year decline in Adjusted EBITDA. The company's sales volume rose to 2.9 million tons, supported by strong Brazilian operations. …
Soleus Capital Master Fund, L.P. and associated entities have reported a beneficial ownership of 2.8% in Vericel Corp (VCEL) common stock, totaling 1,458,882 shares. This updated disclosure, filed on an amended Schedule 13G, places their ownership below the 5% threshold, indicating passive investment. All …
Cellebrite DI Ltd. (CLBT) reported Q2 earnings of $0.11 per share, missing the Zacks Consensus Estimate of $0.12, and revenues of $131.14 million, which also fell short of expectations. The company's shares have declined by 15.4% year-to-date, contrasting with the S&P 500's gain, and …
Cellebrite DI Ltd.'s Global Chief Revenue Officer, Jewell Marcus, sold 411 ordinary shares on August 12, 2026, at a weighted average price of $16.0678 per share. This transaction was executed to cover tax obligations related to the vesting of Restricted Stock Units (RSUs) granted …
Accelerant Holdings (ARX) has entered into a definitive agreement to be acquired by Thoma Bravo in an all-cash merger valued at over $4 billion. Shareholders will receive $20.25 per share, representing a 49% premium to the August 12, 2026 closing price. The deal, supported …
Investing.com - U.S. stock index futures pointed higher on Thursday, as investors digested fresh corporate earnings and deal news while continuing to assess the outlook for inflation and interest rates. By 06:19 ET (10:19 GMT), the Dow futures contract had risen by 112 points, …
(RTTNews) - Cellectar Biosciences, Inc. (CLRB) reported second-quarter 2026 results, highlighting increased R&D investment and a stronger balance sheet compared to the prior year. The company advanced its oncology pipeline with progress in pivotal and early-stage trials, while preparing for a Phase 3 confirmatory …
Search by ticker symbol or company name and select a result to open its chart. The US only control limits results to active US-listed stocks and ETFs.
Showing active US-listed stocks and ETFs only.